All In Biotech

Free tool

FAERS Monitor: Briviact

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205837 or its brand name (Briviact, Brivaracetam). Reports on generic versions are filed under their own applications.

Reports

9,327

Serious

7,450

80% of reports

Hospitalization

2,552

Death reported

467

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure3,353
  • off label use1,195
  • drug ineffective1,051
  • fatigue600
  • therapy interrupted545
  • somnolence532
  • overdose516
  • dizziness479
  • product availability issue403
  • fall381
  • generalised tonic-clonic seizure360
  • epilepsy352
  • product dose omission issue349
  • product use issue320
  • headache315

Reports by year received

View as table
YearReports
20101
20121
20142
20155
2016107
2017231
2018435
2019773
2020692
2021931
20221,034
20231,205
20241,261
20251,396
20261,253

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,832 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
seizureSignal3,35367.465.5214,043
generalised tonic-clonic seizureSignal36050.145.216,921
product availability issueSignal40340.636.915,274
epilepsySignal35226.323.78,440
therapy interruptedSignal54517.316.08,330
somnolenceSignal5326.05.52,212
overdoseSignal5165.45.01,863
product use issueSignal3203.83.5676
off label useSignal1,1953.12.91,747
product dose omission issueSignal3492.72.4370
fallSignal3812.62.3374
dizzinessSignal4792.22.0307
drug ineffective1,0511.81.7397
fatigue6001.71.6195
headache3151.11.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.